Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 673

1.

Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial.

Oliva F, Latini R, Politi A, Staszewsky L, Maggioni AP, Nicolis E, Mauri F.

Am Heart J. 1999 Aug;138(2 Pt 1):247-53.

PMID:
10426835
2.

Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine.

Stanek B, Sturm B, Frey B, Hülsmann M, Bojic A, Berger R, Rödler S, Locker G, Grimm M, Laufer G, Pacher R.

J Heart Lung Transplant. 1999 Apr;18(4):358-66.

PMID:
10226901
3.

Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.

Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S.

Am Heart J. 2003 Mar;145(3):459-66.

PMID:
12660669
4.

Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.

Drakos SG, Kanakakis JV, Nanas S, Bonios M, Kaldara E, Katsaros F, Pantsios C, Nanas JN.

J Cardiovasc Pharmacol. 2009 Feb;53(2):157-61. doi: 10.1097/FJC.0b013e31819846cd.

PMID:
19188832
5.

A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure.

Rich MW, Woods WL, Davila-Roman VG, Morello PJ, Kurz H, Barbarash R, Spinner L, Sperry J, Beckham V, Coulter L, et al.

J Am Geriatr Soc. 1995 Mar;43(3):271-4.

PMID:
7884117
6.

Dobutamine effects on spontaneous variability of ventricular arrhythmias in patients with severe chronic heart failure: the Italian Multicenter Study.

Puddu PE, Papalia U, Schiariti M, Usta C; Do.S.I.M. Investigators of the Italian Interuniversity Cardiology Group..

Ital Heart J. 2004 Sep;5(9):693-701.

PMID:
15568599
7.
8.

Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure.

Hatzizacharias A, Makris T, Krespi P, Triposkiadis F, Voyatzi P, Dalianis N, Kyriakidis M.

Am Heart J. 1999 Aug;138(2 Pt 1):241-6.

PMID:
10426834
9.

Amiodarone attenuates the proarrhythmic effects of dobutamine in patients with advanced congestive heart failure.

Tsagalou EP, Gounopoulos P, Terrovitis JV, Drakos SG, Katsaros FT, Kaldara EE, Alexopoulos GP, Anastasiou-Nana MI.

Hellenic J Cardiol. 2009 May-Jun;50(3):193-8.

10.

[Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study)].

Skvortsov AA, Mareev VIu, Nasonova SN, Sychev AV, Arbolishvili GN, Baklanova NA, Masenko VP, Belenkov IuN.

Ter Arkh. 2006;78(8):14-20. Russian.

PMID:
17078211
11.

Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.

Scrutinio D, Napoli V, Passantino A, Ricci A, Lagioia R, Rizzon P.

Eur Heart J. 2000 Jun;21(11):927-34.

PMID:
10806017
12.
13.

[Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].

La Vecchia L, Bottero M, Centofante P, Bedogni F, Ometto R, Cera A, Fortunato A.

G Ital Cardiol. 1996 Aug;26(8):863-74. Italian.

PMID:
9005168
14.

Intermittent dobutamine hydrochloride infusions in outpatients with chronic congestive heart failure.

Roffman DS, Applefeld MM, Grove WR, Talesnick BS, Sutton FJ, Newman KA, Reed WP.

Clin Pharm. 1985 Mar-Apr;4(2):195-9.

PMID:
3987220
15.

Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results.

Pacher R, Stanek B, Hülsmann M, Berger R, Siegel A, Daneschvar H, Rödler S, Frey B, Grimm M, Laufer G.

Eur Heart J. 1997 Feb;18(2):318-29.

PMID:
9043849
18.
19.

Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators.

Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, Hutchins S, Leier CV, LeJemtel TH, Loh E, Nicklas J, Ogilby D, Singh BN, Smith W.

Circulation. 2000 Oct 31;102(18):2222-7.

20.

[Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of SADKO-CHF study). Part 2].

Skvortsov AA, Mareev VIu, Nasonova SN, Sychev AV, Arbolishvili GN, Baklanova NA, Masenko VP, Belenkov IuN.

Ter Arkh. 2006;78(9):61-71. Russian.

PMID:
17076227

Supplemental Content

Support Center